Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction is a research paper published in JAMA (2022). On theSindex it has a DataRank of 1.4. It has been cited 62 times, with 51 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.621
From this paper's citation signal
Citation Network Contribution
0.782
From 36 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 51 citers.
NHLBI NIH HHS
Grant: R01 HL131029
NHLBI NIH HHS
Grant: R01 HL151841
NHLBI NIH HHS
Grant: R01 HL159514
National Institutes of Health
Grant: 5R01HL159514-03
Characterization of Functional Iron Deficiency and Repletion in Heart Failure with Preserved Ejection Fraction
National Institutes of Health
Grant: 5R01HL151841-03
Characterization of Molecular and Physiologic Signatures of Impaired Multi-Organ System Reserve Capacity During Exercise in Heart Failure with Preserved Ejection Fraction
National Institutes of Health
Grant: 5R01HL131029-03
Comprehensive Metabolic Profiling of Exercise to Predict Cardiometabolic Risk
FWCI
8.45
Citation Percentile
1.0%
Influential Citations
4
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals